AAFP backs FDA tentative trans fats determination

January 7, 2014
AAFP backs FDA tentative trans fats determination

(HealthDay)—The American Academy of Family Physicians (AAFP) has expressed their support for the U.S. Food and Drug Administration's tentative determination regarding partially hydrogenated oils (PHOs) as food additives.

Noting that PHOs have been used in food for many years based on self-determinations that such use is generally safe, Jeffrey J. Cain, M.D., board chair of the AAFP, responded via letter to the FDA's request for comments about the tentative determination regarding PHOs. If the tentative determination is finalized, food manufacturers will no longer be allowed to sell PHOs unless the manufacturer has received FDA approval.

In a literature review, members of the AAFP's Americans in Motion-Healthy Interventions initiative panel found that PHOs contribute to obesity in children and adults, have adverse effects on , increase the risk of , and contribute to insulin resistance.

"The AAFP reviewed the scientific evidence cited and we are pleased to wholeheartedly support the FDA's determination that PHOs are not generally safe for use in food," Cain writes in the letter.

Explore further: AAFP to Obama: Family docs key in violence prevention

More information: More Information

Related Stories

AAFP to Obama: Family docs key in violence prevention

January 25, 2013

(HealthDay)—Family physicians can play a role in addressing and preventing violence in the community, according to a Jan. 17 letter to President Obama from the American Association of Family Physicians (AAFP).

IPAs and PHOs viable option for small independent practices

August 9, 2013

(HealthDay)—For small and medium-size independent practices, sharing care management and information technology resources with other practices through an independent practice association (IPA) or physician-hospital organization ...

FDA encourages opioid prescribers to pursue training

March 12, 2013

(HealthDay)—Prescribers of extended-release/long-acting (ER/LA) opioid analgesics are encouraged to participate in continuing medical education (CME) provided by manufacturers of these analgesics, according to an open letter ...

Recommended for you

Researchers identify source of opioids' side effects

January 17, 2017

A commercially available drug may help drastically reduce two side effects of opioid painkillers—a growing tolerance and a paradoxical increased sensitivity to pain—without affecting the drugs' ability to reduce pain, ...

CVS generic competitor to EpiPen, sold at a 6th the price

January 12, 2017

CVS is now selling a rival, generic version of Mylan's EpiPen at about a sixth of its price, just months after the maker of the life-saving allergy treatment was eviscerated before Congress because of its soaring cost to ...

Many misuse OTC sleep aids: survey

December 29, 2016

(HealthDay)—People struggling with insomnia often turn to non-prescription sleep remedies that may be habit-forming and are only intended for short-term use, according to a new Consumer Reports survey.

The pill won't kill your sexual desire, researchers say

December 15, 2016

Taking the pill doesn't lower your sexual desire, contrary to popular belief, according to research published in the Journal of Sexual Medicine. The authors of the research, from the University of Kentucky and Indiana University ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.